Rik Verheijden

PHD Candidate - OIO

Strategic program(s):

Contact

rverhei6@umcutrecht.nl

Pure profile

Recent publications

All publications

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova, Noël M M Dautzenberg, Mark Schuiveling, Rik J Verheijden, Fiona D M van Schaik, Bas Oldenburg, Stefan Nierkens, Karijn P M Suijkerbuijk, Femke van Wijk,
Communications medicine, 2026, vol. 6

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer E J van Dijk, M M Smeenk, F Bensch, A M Sadowksa, M V Verschueren, M Verhaert, A Llobell, Y Suzuki, D F L Liew, A Takeji, A T J Maria, B J M Peters, J S Garcia Morillo, K Chatzidionysiou, M Lidar, E C van der Hout, S Aspeslagh, G J M Herder, E M W van de Garde, L E L Hendriks, L B M Hijmering-Kappelle, W S M E Theelen, K P M Suijkerbuijk, R J Verheijden
ESMO open, 2026, vol. 11

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova, Noël M M Dautzenberg, Mark Schuiveling, Rik J Verheijden, Fiona D M van Schaik, Bas Oldenburg, Stefan Nierkens, Karijn P M Suijkerbuijk, Femke van Wijk,
Communications medicine, 2025, vol. 5, p.1-14

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma Mark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, Janneke C van der Weerd, Rik J Verheijden, Franchette van den Berkmortel, Christian U Blank, Gerben E Breimer, Femke H Burgers, Marye Boers-Sonderen, Alfons J M van den Eertwegh, Jan Willem B de Groot, John B A G Haanen, Geke A P Hospers, Ellen Kapiteijn, Djura Piersma, Gerard Vreugdenhil, Hans Westgeest, Anne M R Schrader, Josien P W Pluim, Paul J van Diest, Mitko Veta, Karijn P M Suijkerbuijk, Willeke A M Blokx
JAMA Oncology, 2025, vol. 11, p.1470-1478

Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment S Van Dam, D Krijgsman, E Küçükköse, M E L Verdonschot, M Amini, W A M Blokx, M J M Van Eijs, R J Verheijden, O Kranenburg, K P M Suijkerbuijk, J H W Leusen, Y Vercoulen
British Journal of Cancer, 2025, vol. 133, p.1250-1264

Balancing efficacy and toxicity of immune checkpoint inhibitors Rik Verheijden
2025